Olopatadine Hydrochloride 00536-1307-23
- Manufacturer
- Rugby Laboratories
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- January 15, 2021
- Listing Expires
- December 31, 2027
- Application
- ANDA209752
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 2 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Selected Package
00536-1307-23Selected1 BOTTLE, DROPPER in 1 CARTON (0536-1307-23) / 2.5 mL in 1 BOTTLE, DROPPER